M.Pharm

Walk in Interview will be held on 01.05.2017 at 2.30 pm in the Conference Room, Secretariat Building of NIPER for temporary positions under following projects:

Post : SRF - 02 posts

Vegesna Laboratories is a private limited company promoted by V.V. Suryanarayana Raju, a Technocrat promoter and also first generation entrepreneur. Raju is a graduate in Science and with humble beginning as a Chemist with Dr. Reddy’s Labortories Limited rose to Head of one of its plants quickly, due to his dedication and commitment. Raju actively participated in setting up new facility from conceptual stage to implementation, thus became obvious choice to head the facility. With this got excellent scope to understand nitty-gritty’s of overall operations of bulk drug manufacturing thus contributing positively to DRL’s overall performance.

Sai Life Sciences delivers advanced Discovery, Contract Development and Manufacturing Solutions, through a broad suite of expert capabilities across the molecular lifecycle.

Post : Executive/Senior Executive

Par Pharmaceutical merging the business with Endo's Qualitest, thereby expanding the generics business to a top five industry leader.  Endo is highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland and U.S. headquarters in Malvern, PA.

Post : PHARMACEUTICAL PROFESSIONALS

The Department of Pharmaceuticals was created on the 1st of July in the year 2008 in the Ministry of Chemicals & Fertilizers so as to provide greater focus for the growth of the high potential Pharmaceuticals industry.  Shri Ananth Kumar is the Minister of Chemical and Fertilizers and Shri Mansukh L. Mandaviya is the Minister of State for Chemicals and Fertilizers.

Post  : Consultant

Incorporated in the year 1994, Syngene International is one of India"s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area. Based in Bangalore, Karnataka, the Company is situated in a 90 acre Special Economic Zone with over 100000 sq. mt of built up facilities.

Advinus Therapeutics (A TATA Enterprise) is an R&D driven company that is focused on the new drug discovery and development of pharmaceutical and agrochemical products. Advinus operations are organized into two separate businesses centered around Discovery and Development respectively. The Discovery arm of Advinus integrates under one umbrella the expertise, experience, capabilities and infrastructure needed for Drug Discovery from hit to clinical development candidate. Our presence in India helps us enhance the productivity and efficiency of our agrochemical and pharmaceutical R&D programs to unprecedented levels of cost-effectiveness and quality by bringing together demonstrated world class expertise with the talent and economies of India.

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post : Associate Business analyst /Business analyst

The Banting Postdoctoral Fellowships program is one of a suite of elite federal research capacity development programs. The suite begins with early graduate student support through Vanier Canada Graduate Scholarships, progresses to postdoctoral training through the Banting Postdoctoral Fellowships program and continues through the academic career progression (Tier 1 and 2 Canada Research Chairs) to a career pinnacle with the Canada Excellence Research Chairs, and announced in 2014, the Canada First Research Excellence Fund.